Global Intravitreal Injectable Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
ReportID: 542768
|
Published Date: 2024/07/06
|
No. of Pages: 165
|
Categories: Life Sciences
|
Format : 
The global Intravitreal Injectable market was valued at 1378.86 Million USD in 2020 and will grow with a CAGR of 6.91% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%. North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
By Market Verdors:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
By Types:
Anti-VEGF
Steroids
By Applications:
Application A
Application B
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%. North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
By Market Verdors:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
By Types:
Anti-VEGF
Steroids
By Applications:
Application A
Application B
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Intravitreal Injectable Market Size Analysis from 2022 to 2027
1.5.1 Global Intravitreal Injectable Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Intravitreal Injectable Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Intravitreal Injectable Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Intravitreal Injectable Industry Impact
Chapter 2 Global Intravitreal Injectable Competition by Types, Applications, and Top Regions and Countries
2.1 Global Intravitreal Injectable (Volume and Value) by Type
2.1.1 Global Intravitreal Injectable Consumption and Market Share by Type (2016-2021)
2.1.2 Global Intravitreal Injectable Revenue and Market Share by Type (2016-2021)
2.2 Global Intravitreal Injectable (Volume and Value) by Application
2.2.1 Global Intravitreal Injectable Consumption and Market Share by Application (2016-2021)
2.2.2 Global Intravitreal Injectable Revenue and Market Share by Application (2016-2021)
2.3 Global Intravitreal Injectable (Volume and Value) by Regions
2.3.1 Global Intravitreal Injectable Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Intravitreal Injectable Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Intravitreal Injectable Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Intravitreal Injectable Consumption by Regions (2016-2021)
4.2 North America Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.10 South America Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Intravitreal Injectable Market Analysis
5.1 North America Intravitreal Injectable Consumption and Value Analysis
5.1.1 North America Intravitreal Injectable Market Under COVID-19
5.2 North America Intravitreal Injectable Consumption Volume by Types
5.3 North America Intravitreal Injectable Consumption Structure by Application
5.4 North America Intravitreal Injectable Consumption by Top Countries
5.4.1 United States Intravitreal Injectable Consumption Volume from 2016 to 2021
5.4.2 Canada Intravitreal Injectable Consumption Volume from 2016 to 2021
5.4.3 Mexico Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 6 East Asia Intravitreal Injectable Market Analysis
6.1 East Asia Intravitreal Injectable Consumption and Value Analysis
6.1.1 East Asia Intravitreal Injectable Market Under COVID-19
6.2 East Asia Intravitreal Injectable Consumption Volume by Types
6.3 East Asia Intravitreal Injectable Consumption Structure by Application
6.4 East Asia Intravitreal Injectable Consumption by Top Countries
6.4.1 China Intravitreal Injectable Consumption Volume from 2016 to 2021
6.4.2 Japan Intravitreal Injectable Consumption Volume from 2016 to 2021
6.4.3 South Korea Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 7 Europe Intravitreal Injectable Market Analysis
7.1 Europe Intravitreal Injectable Consumption and Value Analysis
7.1.1 Europe Intravitreal Injectable Market Under COVID-19
7.2 Europe Intravitreal Injectable Consumption Volume by Types
7.3 Europe Intravitreal Injectable Consumption Structure by Application
7.4 Europe Intravitreal Injectable Consumption by Top Countries
7.4.1 Germany Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.2 UK Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.3 France Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.4 Italy Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.5 Russia Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.6 Spain Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.7 Netherlands Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.8 Switzerland Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.9 Poland Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 8 South Asia Intravitreal Injectable Market Analysis
8.1 South Asia Intravitreal Injectable Consumption and Value Analysis
8.1.1 South Asia Intravitreal Injectable Market Under COVID-19
8.2 South Asia Intravitreal Injectable Consumption Volume by Types
8.3 South Asia Intravitreal Injectable Consumption Structure by Application
8.4 South Asia Intravitreal Injectable Consumption by Top Countries
8.4.1 India Intravitreal Injectable Consumption Volume from 2016 to 2021
8.4.2 Pakistan Intravitreal Injectable Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Intravitreal Injectable Market Analysis
9.1 Southeast Asia Intravitreal Injectable Consumption and Value Analysis
9.1.1 Southeast Asia Intravitreal Injectable Market Under COVID-19
9.2 Southeast Asia Intravitreal Injectable Consumption Volume by Types
9.3 Southeast Asia Intravitreal Injectable Consumption Structure by Application
9.4 Southeast Asia Intravitreal Injectable Consumption by Top Countries
9.4.1 Indonesia Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.2 Thailand Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.3 Singapore Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.4 Malaysia Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.5 Philippines Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.6 Vietnam Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.7 Myanmar Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 10 Middle East Intravitreal Injectable Market Analysis
10.1 Middle East Intravitreal Injectable Consumption and Value Analysis
10.1.1 Middle East Intravitreal Injectable Market Under COVID-19
10.2 Middle East Intravitreal Injectable Consumption Volume by Types
10.3 Middle East Intravitreal Injectable Consumption Structure by Application
10.4 Middle East Intravitreal Injectable Consumption by Top Countries
10.4.1 Turkey Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.3 Iran Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.5 Israel Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.6 Iraq Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.7 Qatar Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.8 Kuwait Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.9 Oman Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 11 Africa Intravitreal Injectable Market Analysis
11.1 Africa Intravitreal Injectable Consumption and Value Analysis
11.1.1 Africa Intravitreal Injectable Market Under COVID-19
11.2 Africa Intravitreal Injectable Consumption Volume by Types
11.3 Africa Intravitreal Injectable Consumption Structure by Application
11.4 Africa Intravitreal Injectable Consumption by Top Countries
11.4.1 Nigeria Intravitreal Injectable Consumption Volume from 2016 to 2021
11.4.2 South Africa Intravitreal Injectable Consumption Volume from 2016 to 2021
11.4.3 Egypt Intravitreal Injectable Consumption Volume from 2016 to 2021
11.4.4 Algeria Intravitreal Injectable Consumption Volume from 2016 to 2021
11.4.5 Morocco Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 12 Oceania Intravitreal Injectable Market Analysis
12.1 Oceania Intravitreal Injectable Consumption and Value Analysis
12.2 Oceania Intravitreal Injectable Consumption Volume by Types
12.3 Oceania Intravitreal Injectable Consumption Structure by Application
12.4 Oceania Intravitreal Injectable Consumption by Top Countries
12.4.1 Australia Intravitreal Injectable Consumption Volume from 2016 to 2021
12.4.2 New Zealand Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 13 South America Intravitreal Injectable Market Analysis
13.1 South America Intravitreal Injectable Consumption and Value Analysis
13.1.1 South America Intravitreal Injectable Market Under COVID-19
13.2 South America Intravitreal Injectable Consumption Volume by Types
13.3 South America Intravitreal Injectable Consumption Structure by Application
13.4 South America Intravitreal Injectable Consumption Volume by Major Countries
13.4.1 Brazil Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.2 Argentina Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.3 Columbia Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.4 Chile Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.5 Venezuela Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.6 Peru Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.8 Ecuador Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Intravitreal Injectable Business
14.1 Regeneron Pharmaceuticals (Eylea)
14.1.1 Regeneron Pharmaceuticals (Eylea) Company Profile
14.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Specification
14.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Allergan
14.2.1 Allergan Company Profile
14.2.2 Allergan Intravitreal Injectable Product Specification
14.2.3 Allergan Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 EyePoint Pharmaceuticals
14.3.1 EyePoint Pharmaceuticals Company Profile
14.3.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Specification
14.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Genentech
14.4.1 Genentech Company Profile
14.4.2 Genentech Intravitreal Injectable Product Specification
14.4.3 Genentech Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Kanghong Pharmaceutical
14.5.1 Kanghong Pharmaceutical Company Profile
14.5.2 Kanghong Pharmaceutical Intravitreal Injectable Product Specification
14.5.3 Kanghong Pharmaceutical Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Intravitreal Injectable Market Forecast (2022-2027)
15.1 Global Intravitreal Injectable Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Intravitreal Injectable Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Intravitreal Injectable Value and Growth Rate Forecast (2022-2027)
15.2 Global Intravitreal Injectable Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Intravitreal Injectable Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Intravitreal Injectable Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Intravitreal Injectable Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Intravitreal Injectable Consumption Forecast by Type (2022-2027)
15.3.2 Global Intravitreal Injectable Revenue Forecast by Type (2022-2027)
15.3.3 Global Intravitreal Injectable Price Forecast by Type (2022-2027)
15.4 Global Intravitreal Injectable Consumption Volume Forecast by Application (2022-2027)
15.5 Intravitreal Injectable Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Intravitreal Injectable Market Size Analysis from 2022 to 2027
1.5.1 Global Intravitreal Injectable Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Intravitreal Injectable Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Intravitreal Injectable Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Intravitreal Injectable Industry Impact
Chapter 2 Global Intravitreal Injectable Competition by Types, Applications, and Top Regions and Countries
2.1 Global Intravitreal Injectable (Volume and Value) by Type
2.1.1 Global Intravitreal Injectable Consumption and Market Share by Type (2016-2021)
2.1.2 Global Intravitreal Injectable Revenue and Market Share by Type (2016-2021)
2.2 Global Intravitreal Injectable (Volume and Value) by Application
2.2.1 Global Intravitreal Injectable Consumption and Market Share by Application (2016-2021)
2.2.2 Global Intravitreal Injectable Revenue and Market Share by Application (2016-2021)
2.3 Global Intravitreal Injectable (Volume and Value) by Regions
2.3.1 Global Intravitreal Injectable Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Intravitreal Injectable Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Intravitreal Injectable Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Intravitreal Injectable Consumption by Regions (2016-2021)
4.2 North America Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
4.10 South America Intravitreal Injectable Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Intravitreal Injectable Market Analysis
5.1 North America Intravitreal Injectable Consumption and Value Analysis
5.1.1 North America Intravitreal Injectable Market Under COVID-19
5.2 North America Intravitreal Injectable Consumption Volume by Types
5.3 North America Intravitreal Injectable Consumption Structure by Application
5.4 North America Intravitreal Injectable Consumption by Top Countries
5.4.1 United States Intravitreal Injectable Consumption Volume from 2016 to 2021
5.4.2 Canada Intravitreal Injectable Consumption Volume from 2016 to 2021
5.4.3 Mexico Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 6 East Asia Intravitreal Injectable Market Analysis
6.1 East Asia Intravitreal Injectable Consumption and Value Analysis
6.1.1 East Asia Intravitreal Injectable Market Under COVID-19
6.2 East Asia Intravitreal Injectable Consumption Volume by Types
6.3 East Asia Intravitreal Injectable Consumption Structure by Application
6.4 East Asia Intravitreal Injectable Consumption by Top Countries
6.4.1 China Intravitreal Injectable Consumption Volume from 2016 to 2021
6.4.2 Japan Intravitreal Injectable Consumption Volume from 2016 to 2021
6.4.3 South Korea Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 7 Europe Intravitreal Injectable Market Analysis
7.1 Europe Intravitreal Injectable Consumption and Value Analysis
7.1.1 Europe Intravitreal Injectable Market Under COVID-19
7.2 Europe Intravitreal Injectable Consumption Volume by Types
7.3 Europe Intravitreal Injectable Consumption Structure by Application
7.4 Europe Intravitreal Injectable Consumption by Top Countries
7.4.1 Germany Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.2 UK Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.3 France Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.4 Italy Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.5 Russia Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.6 Spain Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.7 Netherlands Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.8 Switzerland Intravitreal Injectable Consumption Volume from 2016 to 2021
7.4.9 Poland Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 8 South Asia Intravitreal Injectable Market Analysis
8.1 South Asia Intravitreal Injectable Consumption and Value Analysis
8.1.1 South Asia Intravitreal Injectable Market Under COVID-19
8.2 South Asia Intravitreal Injectable Consumption Volume by Types
8.3 South Asia Intravitreal Injectable Consumption Structure by Application
8.4 South Asia Intravitreal Injectable Consumption by Top Countries
8.4.1 India Intravitreal Injectable Consumption Volume from 2016 to 2021
8.4.2 Pakistan Intravitreal Injectable Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Intravitreal Injectable Market Analysis
9.1 Southeast Asia Intravitreal Injectable Consumption and Value Analysis
9.1.1 Southeast Asia Intravitreal Injectable Market Under COVID-19
9.2 Southeast Asia Intravitreal Injectable Consumption Volume by Types
9.3 Southeast Asia Intravitreal Injectable Consumption Structure by Application
9.4 Southeast Asia Intravitreal Injectable Consumption by Top Countries
9.4.1 Indonesia Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.2 Thailand Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.3 Singapore Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.4 Malaysia Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.5 Philippines Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.6 Vietnam Intravitreal Injectable Consumption Volume from 2016 to 2021
9.4.7 Myanmar Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 10 Middle East Intravitreal Injectable Market Analysis
10.1 Middle East Intravitreal Injectable Consumption and Value Analysis
10.1.1 Middle East Intravitreal Injectable Market Under COVID-19
10.2 Middle East Intravitreal Injectable Consumption Volume by Types
10.3 Middle East Intravitreal Injectable Consumption Structure by Application
10.4 Middle East Intravitreal Injectable Consumption by Top Countries
10.4.1 Turkey Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.3 Iran Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.5 Israel Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.6 Iraq Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.7 Qatar Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.8 Kuwait Intravitreal Injectable Consumption Volume from 2016 to 2021
10.4.9 Oman Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 11 Africa Intravitreal Injectable Market Analysis
11.1 Africa Intravitreal Injectable Consumption and Value Analysis
11.1.1 Africa Intravitreal Injectable Market Under COVID-19
11.2 Africa Intravitreal Injectable Consumption Volume by Types
11.3 Africa Intravitreal Injectable Consumption Structure by Application
11.4 Africa Intravitreal Injectable Consumption by Top Countries
11.4.1 Nigeria Intravitreal Injectable Consumption Volume from 2016 to 2021
11.4.2 South Africa Intravitreal Injectable Consumption Volume from 2016 to 2021
11.4.3 Egypt Intravitreal Injectable Consumption Volume from 2016 to 2021
11.4.4 Algeria Intravitreal Injectable Consumption Volume from 2016 to 2021
11.4.5 Morocco Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 12 Oceania Intravitreal Injectable Market Analysis
12.1 Oceania Intravitreal Injectable Consumption and Value Analysis
12.2 Oceania Intravitreal Injectable Consumption Volume by Types
12.3 Oceania Intravitreal Injectable Consumption Structure by Application
12.4 Oceania Intravitreal Injectable Consumption by Top Countries
12.4.1 Australia Intravitreal Injectable Consumption Volume from 2016 to 2021
12.4.2 New Zealand Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 13 South America Intravitreal Injectable Market Analysis
13.1 South America Intravitreal Injectable Consumption and Value Analysis
13.1.1 South America Intravitreal Injectable Market Under COVID-19
13.2 South America Intravitreal Injectable Consumption Volume by Types
13.3 South America Intravitreal Injectable Consumption Structure by Application
13.4 South America Intravitreal Injectable Consumption Volume by Major Countries
13.4.1 Brazil Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.2 Argentina Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.3 Columbia Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.4 Chile Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.5 Venezuela Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.6 Peru Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Intravitreal Injectable Consumption Volume from 2016 to 2021
13.4.8 Ecuador Intravitreal Injectable Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Intravitreal Injectable Business
14.1 Regeneron Pharmaceuticals (Eylea)
14.1.1 Regeneron Pharmaceuticals (Eylea) Company Profile
14.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Specification
14.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Allergan
14.2.1 Allergan Company Profile
14.2.2 Allergan Intravitreal Injectable Product Specification
14.2.3 Allergan Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 EyePoint Pharmaceuticals
14.3.1 EyePoint Pharmaceuticals Company Profile
14.3.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Specification
14.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Genentech
14.4.1 Genentech Company Profile
14.4.2 Genentech Intravitreal Injectable Product Specification
14.4.3 Genentech Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Kanghong Pharmaceutical
14.5.1 Kanghong Pharmaceutical Company Profile
14.5.2 Kanghong Pharmaceutical Intravitreal Injectable Product Specification
14.5.3 Kanghong Pharmaceutical Intravitreal Injectable Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Intravitreal Injectable Market Forecast (2022-2027)
15.1 Global Intravitreal Injectable Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Intravitreal Injectable Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Intravitreal Injectable Value and Growth Rate Forecast (2022-2027)
15.2 Global Intravitreal Injectable Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Intravitreal Injectable Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Intravitreal Injectable Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Intravitreal Injectable Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Intravitreal Injectable Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Intravitreal Injectable Consumption Forecast by Type (2022-2027)
15.3.2 Global Intravitreal Injectable Revenue Forecast by Type (2022-2027)
15.3.3 Global Intravitreal Injectable Price Forecast by Type (2022-2027)
15.4 Global Intravitreal Injectable Consumption Volume Forecast by Application (2022-2027)
15.5 Intravitreal Injectable Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Published On:2024/07/06
Base Year:
Historical Data:
No of Pages:165
Price
Global Intravitreal Injectable Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2031
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
